FR3026009B1 - Nanocapsules lipidiques, compositions pharmaceutiques, procede de preparation, et utilisations correspondants - Google Patents

Nanocapsules lipidiques, compositions pharmaceutiques, procede de preparation, et utilisations correspondants Download PDF

Info

Publication number
FR3026009B1
FR3026009B1 FR1458991A FR1458991A FR3026009B1 FR 3026009 B1 FR3026009 B1 FR 3026009B1 FR 1458991 A FR1458991 A FR 1458991A FR 1458991 A FR1458991 A FR 1458991A FR 3026009 B1 FR3026009 B1 FR 3026009B1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
lipid nanocapsules
nanocapsules
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1458991A
Other languages
English (en)
Other versions
FR3026009A1 (fr
Inventor
Pauline Resnier
Catherine Passirani
Jean-Pierre Benoit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite dAngers
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Universite dAngers
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite dAngers, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Universite dAngers
Priority to FR1458991A priority Critical patent/FR3026009B1/fr
Publication of FR3026009A1 publication Critical patent/FR3026009A1/fr
Application granted granted Critical
Publication of FR3026009B1 publication Critical patent/FR3026009B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1458991A 2014-09-24 2014-09-24 Nanocapsules lipidiques, compositions pharmaceutiques, procede de preparation, et utilisations correspondants Active FR3026009B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1458991A FR3026009B1 (fr) 2014-09-24 2014-09-24 Nanocapsules lipidiques, compositions pharmaceutiques, procede de preparation, et utilisations correspondants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1458991A FR3026009B1 (fr) 2014-09-24 2014-09-24 Nanocapsules lipidiques, compositions pharmaceutiques, procede de preparation, et utilisations correspondants
FR1458991 2014-09-24

Publications (2)

Publication Number Publication Date
FR3026009A1 FR3026009A1 (fr) 2016-03-25
FR3026009B1 true FR3026009B1 (fr) 2018-01-26

Family

ID=52807856

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1458991A Active FR3026009B1 (fr) 2014-09-24 2014-09-24 Nanocapsules lipidiques, compositions pharmaceutiques, procede de preparation, et utilisations correspondants

Country Status (1)

Country Link
FR (1) FR3026009B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3119314A1 (fr) * 2021-01-29 2022-08-05 Advanced Biodesign Nanocapsule lipidique comprenant au moins un composé aminothiolester ou un de ses dérivés pharmaceutiquement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916974B1 (fr) * 2007-06-11 2010-11-26 Univ Angers Procede de preparation de nanoparticules lipidiques

Also Published As

Publication number Publication date
FR3026009A1 (fr) 2016-03-25

Similar Documents

Publication Publication Date Title
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
CL2014003165A1 (es) Proceso mejorado para la preparación de treprostinil y derivados del mismo.
MA50541A (fr) Formulations pharmaceutiques
BR112016023628A2 (pt) composições farmacêuticas.
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
EP3130354A4 (fr) Composition pharmaceutique à base de posaconazole, ainsi que procédé de préparation, utilisation et préparation pharmaceutique de celle-ci
EP3214090A4 (fr) Dérivé de thionucléoside ou sel de celui-ci, et composition pharmaceutique
EP3199162A4 (fr) Produit pharmaceutique
MA42303A (fr) Formulations pharmaceutiques
FR3030536B1 (fr) Organopolysiloxanes et leur procede de preparation
MA54716A (fr) Réduction de la viscosité de formulations pharmaceutiques
MA46867A (fr) Formulations pharmaceutiques
EP3231802A4 (fr) Dérivés du pyridinecarboxamide, méthode de préparation de ces derniers, et utilisations pharmaceutiques de ce derniers
MA45187A (fr) Combinaisons pharmaceutiques
DK3199161T3 (da) Farmaceutisk præparat
DK3212166T3 (da) Varme-steriliseret formulering omfattende chitosan og fremgangsmåde til fremstilling deraf
LU92738B1 (fr) Procede et installation de preparation de biomasse
DK3157506T3 (da) Smagsmaskeret oral, farmaceutisk sammensætning
FR3022234B1 (fr) Procede de preparation de nanofils de silicium.
FI20145305A (fi) Proteiinituotteet ja menetelmät niiden valmistamiseksi
MA41850A (fr) Nouvelles utilisations pharmaceutiques
BR112016027819A2 (pt) Processo de preparação de derivados de tiazole
FR3025798B1 (fr) Procede specifique de preparation de polyesters biosources.
EP3153172A4 (fr) Composition pharmaceutique à base d'arni réprimant la transcription du gène ckap5
FR2986527B1 (fr) Procede de preparation de phosphines tertiaires et de derives de celles-ci.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160325

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10